Welcome to our dedicated page for Nexien Biopharma SEC filings (Ticker: NXEN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
nexien biopharma, a pharmaceutical company, engages in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways to address a range of medical conditions and disorders. the company was formerly known as intiva biopharma inc. and changed its name to nexien biopharma, inc. in september 2018. nexien biopharma, inc. is based in glendale, colorado.Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of Nexien Biopharma (NXEN)?
The current stock price of Nexien Biopharma (NXEN) is $0.012 as of September 26, 2025.
What is the market cap of Nexien Biopharma (NXEN)?
The market cap of Nexien Biopharma (NXEN) is approximately 849.3K.
Nexien Biopharma
OTC:NXEN
NXEN Rankings
NXEN Stock Data
849.27k
31.27M
55.82%
Drug Manufacturers - Specialty & Generic
Healthcare
United States
Glendale